Patents by Inventor Yvonne Stark

Yvonne Stark has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230357398
    Abstract: The present disclosure provides novel fully human antibodies and antibody fragments specific for human CD3 epsilon.
    Type: Application
    Filed: September 22, 2021
    Publication date: November 9, 2023
    Inventors: Andreas BÜLTMANN, Steffen RUNZ, Tschimegma BATAA, Markus MOOSMEIER, Nicole HAUBST, Jürgen KLATTIG, Yvonne STARK
  • Patent number: 10919955
    Abstract: The present invention provides synthetic rodent antibody libraries, such as mouse or rat antibody libraries, as well as polypeptides, nucleic acids, vectors, host cells and methods used in conjunction with these libraries. The present invention also provides antibodies isolated from such libraries and variants of such antibodies.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: February 16, 2021
    Assignee: MORPHOSYS AG
    Inventors: Josef Prassler, David Ott, Stefanie Thiel, Yvonne Stark, Ute Keck, Thomas Pietzonka, Hilmar Ebersbach
  • Publication number: 20170183395
    Abstract: The present invention provides synthetic rodent antibody libraries, such as mouse or rat antibody libraries, as well as polypeptides, nucleic acids, vectors, host cells and methods used in conjunction with these libraries. The present invention also provides antibodies isolated from such libraries and variants of such antibodies.
    Type: Application
    Filed: March 10, 2017
    Publication date: June 29, 2017
    Inventors: Josef Prassler, David Ott, Stefanie Thiel, Yvonne Stark, Ute Keck, Thomas Pietzonka, Hilmar Ebersbach
  • Patent number: 9650432
    Abstract: The present invention provides synthetic rodent antibody libraries, such as mouse or rat antibody libraries, as well as polypeptides, nucleic acids, vectors, host cells and methods used in conjunction with these libraries. The present invention also provides antibodies isolated from such libraries and variants of such antibodies.
    Type: Grant
    Filed: January 28, 2011
    Date of Patent: May 16, 2017
    Assignee: MORPHOSYS AG
    Inventors: Josef Prassler, David Ott, Stefanie Thiel, Yvonne Stark, Ute Keck, Thomas Pietzonka, Hilmar Ebersbach
  • Patent number: 9541559
    Abstract: The present disclosure enables collections of variable heavy chain and variable light chain pairs comprising, in part, germline protein sequences that are pre-selected for functional properties relevant to developability, wherein the collections may be used to select against any antigen using, for example, phage display.
    Type: Grant
    Filed: April 2, 2014
    Date of Patent: January 10, 2017
    Assignee: MORPHOSYS AG
    Inventors: Stefanie Urlinger, Thomas Tiller, Ingrid Schuster, Yvonne Stark
  • Patent number: 9062097
    Abstract: The present invention relates to methods for the formation of inter-molecular disulphide bonds, including (poly)peptides/proteins, nucleic acids, vectors, host cells and bacteriophages used in these methods. Furthermore the invention relates to the use of this method for the improved display of (poly)peptides/proteins on the surface of bacteriophage particles.
    Type: Grant
    Filed: August 21, 2008
    Date of Patent: June 23, 2015
    Assignee: Morpho Sys AG
    Inventors: Josef Prassler, Yvonne Stark
  • Publication number: 20140206575
    Abstract: The present disclosure enables collections of variable heavy chain and variable light chain pairs comprising, in part, germline protein sequences that are pre-selected for functional properties relevant to developability, wherein the collections may be used to select against any antigen using, for example, phage display.
    Type: Application
    Filed: April 2, 2014
    Publication date: July 24, 2014
    Applicant: MorphoSys AG
    Inventors: Stefanie Urlinger, Thomas Tiller, Ingrid Schuster, Yvonne Stark
  • Patent number: 8728981
    Abstract: The present disclosure enables collections of variable heavy chain and variable light chain pairs comprising, in part, germline protein sequences that are pre-selected for functional properties relevant to developability, wherein the collections may be used to select against any antigen using, for example, phage display.
    Type: Grant
    Filed: November 18, 2011
    Date of Patent: May 20, 2014
    Assignee: MorphoSys AG
    Inventors: Stefanie Urlinger, Thomas Tiller, Ingrid Schuster, Yvonne Stark
  • Publication number: 20130236902
    Abstract: The present disclosure enables collections of variable heavy chain and variable light chain pairs comprising, in part, germline protein sequences that are pre-selected for functional properties relevant to developability, wherein the collections may be used to select against any antigen using, for example, phage display.
    Type: Application
    Filed: November 18, 2011
    Publication date: September 12, 2013
    Applicant: MorphoSys AG
    Inventors: Stefanie Urlinger, Thomas Tiller, Ingrid Schuster, Yvonne Stark
  • Patent number: 8367586
    Abstract: The present disclosure enables collections of variable heavy chain and variable light chain pairs comprising, in part, germline protein sequences that are pre-selected for functional properties relevant to developability, wherein the collections may be used to select against any antigen using, for example, phage display.
    Type: Grant
    Filed: November 18, 2011
    Date of Patent: February 5, 2013
    Assignee: MorphoSys AG
    Inventors: Stefanie Urlinger, Thomas Tiller, Ingrid Schuster, Yvonne Stark
  • Publication number: 20130030157
    Abstract: The present invention provides synthetic rodent antibody libraries, such as mouse or rat antibody libraries, as well as polypeptides, nucleic acids, vectors, host cells and methods used in conjunction with these libraries. The present invention also provides antibodies isolated from such libraries and variants of such antibodies.
    Type: Application
    Filed: January 28, 2011
    Publication date: January 31, 2013
    Applicant: MORPHOSYS AG
    Inventors: Josef Prassler, David Ott, Stefanie Thiel, Yvonne Stark, Ute Keck, Thomas Pietzonka, Hilmar Ebersbach
  • Patent number: 8206977
    Abstract: A tricistronic vector (i.e., a vector capable of expressing three exogenous genes, which are not fused together, under the control of one promoter) effectively can encode an immunoglobulin-presenting polypeptide and two immunoglobulin (Ig) polypeptides. The encoded Ig-presenting polypeptide is able to associate with at least one of the Ig polypeptides via co-expressed associating agents. A vector according to the present invention particularly is suited for phage display technology, e.g., when the Ig-presenting polypeptide is a phage coat protein and the Ig polypeptides associate to form a Fab.
    Type: Grant
    Filed: July 30, 2003
    Date of Patent: June 26, 2012
    Assignee: MorphoSys AG
    Inventors: Josef Prassler, Yvonne Stark
  • Publication number: 20120129717
    Abstract: The present disclosure enables collections of variable heavy chain and variable light chain pairs comprising, in part, germline protein sequences that are pre-selected for functional properties relevant to developability, wherein the collections may be used to select against any antigen using, for example, phage display.
    Type: Application
    Filed: November 18, 2011
    Publication date: May 24, 2012
    Applicant: MORPHOSYS AG
    Inventors: Stefanie Urlinger, Thomas Tiller, Ingrid Schuster, Yvonne Stark
  • Publication number: 20100190234
    Abstract: The present invention relates to methods for the formation of inter-molecular disulphide bonds, including (poly)peptides/proteins, nucleic acids, vectors, host cells and bacteriophages used in these methods. Furthermore the invention relates to the use of this method for the improved display of (poly)peptides/proteins on the surface of bacteriophage particles.
    Type: Application
    Filed: August 21, 2008
    Publication date: July 29, 2010
    Applicant: MORPHOSYS AG
    Inventors: Josef Prassler, Yvonne Stark
  • Publication number: 20060121563
    Abstract: A tricistronic vector (i.e., a vector capable of expressing three exogenous genet, which are not fused together, under the control of one promoter) effectively can encode an immunoglobulin-presenting polypeptide and two immunoglobulin (Ig) polypeptides. The encoded Ig-presenting polypeptide is able to associate with at least one of the Ig polypeptides via co-expressed associating agents. A vector according to the present invention particularly is suited for phage display technology, e.g., when the Ig-presenting polypeptide is a phage coat protein and the Ig polypeptides associate to form a Fab.
    Type: Application
    Filed: July 30, 2003
    Publication date: June 8, 2006
    Applicant: Morphosys AG
    Inventors: Josef Prassler, Yvonne Stark